A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Local Institution - 0007, Clayton

Local Institution - 0028, Guadalajara

Local Institution - 0023, Taichung

Local Institution - 0021, Taichung

Local Institution - 0031, Kaohsiung City

Local Institution - 0018, Capital Federal

Local Institution - 0019, Buenos Aires

Local Institution - 0003, Botany

Local Institution - 0001, Kogarah

Local Institution - 0078, Melbourne

Local Institution - 0002, Camberwell

Local Institution - 0013, San Miguel de Tucumán

Local Institution - 0087, Victoria Park

Local Institution - 0037, New York

Local Institution - 0022, Taipei

Local Institution - 0035, Berlin

Local Institution - 0071, Mexico City

Local Institution - 0029, Aguascalientes

Local Institution - 0006, Hamburg

Local Institution - 0065, Durham

Local Institution - 0054, Charleston

Local Institution - 0082, Orlando

Local Institution - 0038, Bordeaux

Local Institution - 0067, Columbus

Local Institution, Guadalajara

Local Institution - 0058, Zapopan

Local Institution - 0060, Ann Arbor

Local Institution - 0059, St Louis

Local Institution - 0036, Monterrey

Local Institution - 0026, Oklahoma City

Local Institution - 0010, Paris

Local Institution - 0077, Scottsdale

Local Institution - 0046, Los Angeles

Local Institution - 0014, Erlangen

Local Institution - 0076, Irvine

Local Institution - 0027, Créteil

Local Institution - 0073, Farmington

Local Institution - 0072, Dresden

Local Institution - 0005, Rzeszów

Local Institution - 0009, Wroclaw

Local Institution - 0008, Lodz